Form 4: Senseonics CFO Receives Equity Compensation Grant

Senseonics Holdings CFO Frederick T. Sullivan was granted 90,253 restricted stock units and 124,193 stock options.

Summary

• CFO Frederick T. Sullivan received a grant of 90,253 restricted stock units (RSUs).
• The CFO also received an option to purchase 124,193 shares of common stock at an exercise price of $5.54.
• The RSU grant vests in eight equal installments starting June 15, 2026.
• The stock options vest in 48 equal monthly installments beginning May 19, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral for the stock price.

Positives

• Equity-based compensation aligns the interests of the CFO with long-term shareholder value.

Negatives

• The issuance of new equity and options results in potential future dilution for existing shareholders.

Risks

• Vesting is contingent upon the reporting person's continuous service with the issuer.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on executive compensation.

Industry Context

StockSavvy.ai notes that equity grants for executive leadership are standard practice in the medical technology sector to incentivize long-term retention and performance.

Comparison to Industry Standards

• The use of multi-year vesting schedules for RSUs and options is consistent with standard corporate governance practices for executive compensation in the U.S. biotech and medtech industries.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise and settlement of these equity awards.

Next Steps

• Vesting of RSU installments beginning June 15, 2026.
• Monthly vesting of stock options.

Key Dates

Keywords

Senseonics, SENS, CFO, Insider Trading, Equity Compensation, Form 4